Skip to main content
Top

Cancer Causes & Control

Issue 8/2003

Content (12 Articles)

Intake of vitamins A, C, and E from diet and supplements and breast cancer in postmenopausal women

Stine B. Nissen, Anne Tjønneland, Connie Stripp, Anja Olsen, Jane Christensen, Kim Overvad, Lars O. Dragsted, Birthe Thomsen

Cancer prevention for working class, multi-ethnic populations through health centers: the healthy directions study

Karen M. Emmons, Anne M. Stoddard, Caitlin Gutheil, Elizabeth Gonzalez Suarez, Rebecca Lobb, Robert Fletcher

Hypothesis: is antibiotic use associated with breast cancer?

Christine M. Velicer, Johanna W. Lampe, Susan R. Heckbert, John D. Potter, Stephen H. Taplin

Cancer prevention for working class, multiethnic populations through small businesses: the healthy directions study

Mary K. Hunt, Anne M. Stoddard, Elizabeth Barbeau, Roberta Goldman, Lorraine Wallace, Caitlin Gutheil, Glorian Sorensen

Race, socioeconomic status and stage at diagnosis for five common malignancies

Kendra L. Schwartz, Heather Crossley-May, Fawn D. Vigneau, Karl Brown, Mousumi Banerjee

A pooled analysis of case–control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea

Wendy J. Mack, Susan Preston-Martin, Luigino Dal Maso, Rosaria Galanti, Min Xiang, Silvia Franceschi, Arne Hallquist, Fan Jin, Laurence Kolonel, Carlo La Vecchia, Fabio Levi, Athena Linos, Eiliv Lund, Anne McTiernan, Kiyohiko Mabuchi, Eva Negri, Gun Wingren, Elaine Ron

Thyroid cancer pooled analysis from 14 case–control studies: what have we learned?

Susan Preston-Martin, Silvia Franceschi, Elaine Ron, Eva Negri

Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends

Fabio Montanaro, Freddie Bray, Valerio Gennaro, Enzo Merler, Jerzy E. Tyczynski, Donald Maxwell Parkin

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine